Page 1013 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 1013

CHAPTER 55  Immunopharmacology     999


                    IMMEDIATE (TYPE I) DRUG ALLERGY                      edema in the inflamed tissue, as well as facilitating the actions
                                                                         of catecholamines in cells that may have become refractory to
                    Type I (immediate) sensitivity allergy to certain drugs occurs when   epinephrine or isoproterenol. Several agents directed toward the
                    the drug, not capable of inducing an immune response by itself,   inhibition of leukotrienes may be useful in acute allergic and
                    covalently links to a host carrier protein (hapten). When this hap-  inflammatory disorders (see Chapter 20).
                    pens, the immune system detects the drug-hapten conjugate as
                    “modified self” and responds by generating IgE antibodies specific   Desensitization to Drugs
                    for the drug-hapten. It is not known why some patients mount an   When reasonable alternatives are not available, certain drugs (eg,
                    IgE response to a drug while others mount IgG responses. Under the   penicillin, insulin) must be used for life-threatening illnesses even in
                    influence of IL-4, -5, and -13 secreted by Th2 cells, B cells specific   the presence of known allergic sensitivity. In such cases, desensitiza-
                    for the drug secrete IgE antibody. The mechanism for IgE-mediated   tion (also called hyposensitization) can sometimes be accomplished
                    immediate hypersensitivity is diagrammed in Figure 55–5.  by starting with very small doses of the drug and gradually increas-
                       Fixation of the IgE antibody to high-affinity Fc receptors
                    (FcεRs) on blood basophils or their tissue equivalent (mast cells)   ing the dose over a period of hours or days to the full therapeutic
                                                                         range (see Chapter 43). This practice is hazardous and must be
                    sets the stage for an acute allergic reaction. The most important   performed under direct medical supervision with epinephrine
                    sites for mast cell distribution are skin, nasal epithelium, lung,   available for immediate injection, as anaphylaxis may occur before
                    and gastrointestinal tract.  When the offending drug is reintro-  desensitization has been achieved. It is thought that slow and pro-
                    duced into the body, it binds and cross-links basophil and mast   gressive administration of the drug gradually binds all available IgE
                    cell-surface IgE to signal release of the mediators (eg, histamine,   on mast cells, triggering a gradual release of granules. Once all of
                    leukotrienes; see Chapters 16 and 18) from granules. Mediator   the IgE on the mast cell surfaces has been bound and the cells have
                    release is associated with calcium influx and a fall in intracel-  been degranulated, therapeutic doses of the offending drug may be
                    lular cAMP within the mast cell. Many of the drugs that block   given with minimal further immune reaction. Therefore, a patient
                    mediator release appear to act through the cAMP mechanism   is desensitized only during administration of the drug.
                    (eg, catecholamines, glucocorticoids, theophylline), others block
                    histamine release, and still others block histamine receptors. Other
                    vasoactive substances such as kinins may also be generated during   AUTOIMMUNE (TYPE II) REACTIONS TO
                    histamine release.  These mediators initiate immediate vascular   DRUGS
                    smooth muscle relaxation, increased vascular permeability, hypo-
                    tension, edema, and bronchoconstriction.             Certain autoimmune syndromes can be induced by drugs. Exam-
                                                                         ples include systemic lupus erythematosus following hydralazine
                    Drug Treatment of Immediate Allergy                  or procainamide therapy, “lupoid hepatitis” due to cathartic sensi-
                                                                         tivity, autoimmune hemolytic anemia resulting from methyldopa
                    One can test an individual for possible sensitivity to a drug by a   administration, thrombocytopenic purpura due to quinidine, and
                    simple scratch test, ie, by applying an extremely dilute solution of   agranulocytosis due to a variety of drugs. As indicated in other
                    the drug to the skin and making a scratch with the tip of a needle.   chapters of this book, a number of drugs are associated with type I
                    If allergy is present, an immediate (within 10–15 minutes) wheal   and type II reactions. In these drug-induced autoimmune states,
                    (edema) and flare (increased blood flow) will occur. However, skin   IgG antibodies bind to drug-modified tissue and are destroyed
                    tests may be negative in spite of IgE hypersensitivity to a hapten   by the complement system or by phagocytic cells with Fc recep-
                    or to a metabolic product of the drug, especially if the patient is   tors. Fortunately, autoimmune reactions to drugs usually subside
                    taking steroids or antihistamines.                   within several months after the offending drug is withdrawn.
                       Drugs that modify allergic responses act at several links in this   Immunosuppressive therapy is warranted only when the autoim-
                    chain of events. Prednisone, often used in severe allergic reactions,   mune response is unusually severe.
                    is immunosuppressive; it blocks proliferation of the IgE-producing
                    clones and inhibits IL-4 production by T helper cells in the IgE
                    response, since glucocorticoids are generally toxic to lympho-  SERUM SICKNESS & VASCULITIC
                    cytes. In the efferent limb of the allergic response, isoproterenol,   (TYPE III) REACTIONS
                    epinephrine, and theophylline reduce the release of mediators
                    from mast cells and basophils and produce bronchodilation.   Immunologic reactions to drugs resulting in serum sickness
                    Epinephrine opposes  histamine;  it  relaxes  bronchiolar  smooth   are more common than immediate anaphylactic responses,
                    muscle  and  contracts  vascular  muscle,  relieving  both  broncho-  but type II and type III hypersensitivities often overlap.  The
                    spasm and hypotension.  As noted in  Chapter 8, epinephrine is   clinical features of serum sickness include urticarial and erythema-
                    the drug of choice in anaphylactic reactions. The  antihistamines   tous  skin  eruptions,  arthralgia or  arthritis, lymphadenopathy,
                    competitively inhibit histamine, which would otherwise produce   glomerulonephritis, peripheral edema, and fever. The reactions
                    bronchoconstriction and increased capillary permeability in end   generally last 6–12 days and usually subside once the offending
                    organs. Glucocorticoids may also act to reduce tissue injury and   drug is eliminated. Antibodies of the IgM or IgG class are usually
   1008   1009   1010   1011   1012   1013   1014   1015   1016   1017   1018